ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) Institutional Ownership

CUSIP: 76090R309

13F Institutional Holders and Ownership History from Q3 2024 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
RSLS on Nasdaq
Shares outstanding
3,326,711
Price per share
$0.45
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 76090R309?
CUSIP 76090R309 identifies RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIGGER CAPITAL FUND L P 9.7% $121,600 320,000 Bigger Michael 18 Feb 2025
CVI Investments, Inc. 5.7% -42% $76,000 -$54,958 200,000 -42% CVI Investments, Inc. 31 Mar 2025
FirstFire Global Opportunities Fund LLC 6.1% $76,000 200,000 FirstFire Global Opportunities Fund LLC 18 Feb 2025
Leonite Fund I, LP 6.1% $76,000 200,000 Leonite Fund I, LP 18 Feb 2025
Ayrton Capital LLC 5.7% $76,000 200,000 Ayrton Capital LLC 31 Mar 2025
Dominion Capital LLC 0.76% -91% $9,608 -$20,149 25,283 -68% Dominion Capital LLC 18 Feb 2025

Institutional Holders of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$37,359 $0.45 0
2025 Q1 103,713 $37,359 +$30,463 $0.36 9
2024 Q4 19,112 $85,238 +$79,600 $4.46 9
2024 Q3 1,263 $7,137 +$3,815 $5.88 8